Success Metrics

Clinical Success Rate

50.0%

Based on 2 completed trials

Completion Rate

50%(2/4)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Terminated

2(40%)

Phase Distribution

Ph early_phase_1

20%

Ph phase_1

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(2)

Detailed Status

Completed2

Terminated2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 1

Trials by Phase

Early Phase 11 (20.0%)

Phase 14 (80.0%)

Trials by Status

completed240%

active_not_recruiting120%

terminated240%

Recent Activity

1 active trials

Showing 5 of 5

completedearly_phase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT05291286Early Phase 1

BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients

Completed

NCT04404569Phase 1

Continued Treatment for Participants Enrolled in Studies of BXQ-350

Terminated

NCT05322590Phase 1

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Active Not Recruiting

NCT02859857Phase 1

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

Completed

NCT03967093Phase 1

A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5